Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
October 28, 2019 Cover
Volume 97, Issue 42
ROAR and other UK initiatives aim to democratize access to high-throughput equipment and industrial know-how
Cover image:UK initiatives aim to democratize access to high-throughput equipment and train a new generation of chemists in data-driven synthesis
Credit: Yang H. Ku/C&EN/Shutterstock
Automation for the people: Training a new generation of chemists in data-driven synthesis
ROAR and other UK initiatives aim to democratize access to high-throughput equipment and industrial know-how
The race is on to repurpose garbage
Despite a spotty track record, companies keep trying to convert trash into energy, fuels, and chemicals
Batteries need a boost to fly the friendly skies
Lithium-air batteries are a front-runner to power regional electric air travel, but they haven’t yet left the lab bench
-
Periodic Graphics: Metal-air batteries, present and future
Chemical educator and Compound Interest blogger Andy Brunning supplies the latest on these promising energy-storage devices.
-
Milasen: The drug that went from idea to injection in 10 months
A custom antisense oligonucleotide drug has set records for both personalization and speed in drug development
-
ADVERTISEMENT
Science Concentrates
David Liu unveils a search-and-replace CRISPR tool and a start-up to commercialize it
Beam Therapeutics and a new start-up called Prime Medicine will develop therapies based on prime editors, which can add, remove, or change nucleotides anywhere in the genome
